Major Indexes Hit Record Highs as Oil Prices Slide on USIran Peace Deal Prospects Retail Chain to Close All Stores After 33 Years of Operations Certificate of Deposit Rates Remain Attractive Lock in up to 4 APY as of May 24 2026 UK PM Starmer Pledges Social Media Crackdown Following Parent Meeting Regulation Uncertainty Looms Este Lauder Shares Jump in Premarket as Merger Talks With Puig End Southeast Asias MiddleClass Growth Poses Energy Dilemma WILC Q4 2025 Earnings Strong EPS Reported Amid Limited Data Disclosure Lakeland Industries LAKE Q1 2026 Earnings Deep EPS Miss Masks Potential Recovery as Stock Rallies LOGI Q1 2026 Earnings EPS Slightly Beats Estimates Stock Jumps 646 BW Q1 2026 Earnings EPS Misses Estimates Amid Market Challenges Niagen Bioscience Inc NAGE Q1 2026 Earnings EPS Beats Estimates by 086 but Stock Declines 343 RNGR Q1 2026 Earnings EPS Misses Estimates by Nearly 39 Amid Operational Headwinds Basel Medical Group BMGL Slides 277 as Selling Pressure Intensifies Nears Critical Support Teva Pharmaceuticals Advances 235 as Buyers Test Resistance Near 37 Bone Biologics Corp BBLG Rises 328 as Stock Approaches Resistance Level Wrap Technologies Inc WRAP Edges Higher Amid Low Volume Key Resistance in Focus Park Hotels Resorts PK Rallies 108 as Travel Demand Optimism Returns April Private Payrolls Rise by 109000 Exceeding Expectations ADP Data Signals Stable Labor Market Adaptive Biotechnologies ADPT Q1 2026 Earnings Narrower Loss Beats Consensus Shares Edge Lower Virtu Financial VIRT Dips 385 as Support Levels Come into Focus Globus Maritime GLBS Nears Support After 195 Decline Key Levels for Traders to Monitor EquipmentSharecom Inc EQPT Gains Momentum Shares Climb 56 on Strong Volume GT Biopharma Inc GTBP Falls Over 10 as Biotech Sentiment Weakens AutoZone Inc AZO Faces Sharp Decline Support Levels in Focus After 105 Drop United Parks Resorts PRKS Surges 36 as Stock Approaches Key Resistance BlackRock Science and Technology Trust BST Advances 155 as Growth Stocks Find Favor Hall Chadwick Acquisition Corp Rights HCACR Extends Decline Testing Support at 028